A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Multiple Myeloma Panel by Fish : 1001101
Test CodeMDFCPCMMP or 1001101
Alias/See Also
MM, Fluorescence in situ Hybridization, Multiple myeloma, Dyscrasia, Plasmacytoma, Plasma Cell Myeloma, PCM, MGUS, Plasma Cell Neoplasm
CPT Codes
88271x13, 88275x6
Includes
FISH probes targeting gain of 1q/loss of 1p; MYC (8q24); CEP 9,11,15; D13S319 (13q13.4); IGH (14q32); TP53 (17p13). Reflex: IGH-FGFR3, t(4;14); IGH-CCND1, t(11;14); IGH-MAF, t(14;16); IGH-MAFB, t(14;20).
If the result for IGH rearrangement is positive following initial FISH analysis, then the IGH reflex probes will be performed at an additional charge (CPT® codes(s): 88271 (x8), 88275 (x4)).
If the result for IGH rearrangement is positive following initial FISH analysis, then the IGH reflex probes will be performed at an additional charge (CPT® codes(s): 88271 (x8), 88275 (x4)).
Instructions
3 mL bone marrow collected in a sodium heparin (green-top) tube
Minimum Volume: 1 mL
Minimum Volume: 1 mL
Transport Container
Preferred: Sodium heparin (green-top) tube
Alternative Specimen(s): Bone marrow collected in EDTA (lavender-top) tube
Alternative Specimen(s): Bone marrow collected in EDTA (lavender-top) tube
Transport Temperature
Room temperture
Specimen viability decreases during transit. Send specimen to testing lab for viability determination. Do not freeze. **Do not reject.**
Specimen viability decreases during transit. Send specimen to testing lab for viability determination. Do not freeze. **Do not reject.**
Specimen Stability
Ambient: 48 hours; Refrigerated: 48 hours; Frozen: Unacceptable
Methodology
Fluorescence in situ hybridization (FISH)
Setup Schedule
Monday - Friday
Report Available
Up to 7 days
Limitations
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Reference Range
See Laboratory Report
Clinical Significance
Plasma cell myeloma is characterized by the proliferation of malignant monoclonal plasma cells in the bone marrow. This FISH panel is designed for clinical risk classification. Initial FISH testing is performed to detect deletion of TP53 (17p), rearrangements of IGH (14q32), rearrangements of MYC, gain of 1q, deletion of 1p, deletion of 13q/monosomy 13, and gain (trisomy) of chromosomes 9, 11, and 15 (for hyperdiploidy). When IGH rearrangement is positive, FISH for the specific IGH rearrangements, t(11;14), t(4;14), t(14;16), t(14;20), will be performed.
Performing Laboratory
med fusion